搜索此博客

2019年7月10日星期三

CAS 866245-79-6 ;13415-07-1 (free) Octahydroaminoacridine succinate, Sole GMP Manufacturer

Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  Sole GMP Manufacturer

Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  stable novel crystalline or amorphous form both we have, Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free) no any IP problem. Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  DMF filling, free sample of Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free) .

EOS Med Chem have already carried out Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  Intermeidates list, most from GMP plant:

Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free) Intermediate,  22945-27-3, stock 9.5kg, assay 98.2%, White powder.
Octahydroaminoacridine succinate, CAS 866245-79-6 ;
13415-07-1 (free) Intermediate,  30152-60-4, stock 3.1kg, assay 99%, White powder.
Octahydroaminoacridine succinate, CAS 866245-79-6 ;
13415-07-1 (free) Intermediate,  1477909-59-3, stock 2.6kg, assay 98%, White powder.
Octahydroaminoacridine succinate, CAS 866245-79-6 ;
13415-07-1 (free) Intermediate,  134-50-9, stock 2.1kg, assay 98.6%, White powder.
Octahydroaminoacridine succinate, CAS 866245-79-6 ;
13415-07-1 (free) Intermediate,  157996-59-3, stock 8.7kg, assay 98.5%, White powder.
Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free)  HNMR, MASS, COA, MSDS we have.

Octahydroaminoacridine succinate, CAS 866245-79-6 ;13415-07-1 (free) , free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com